Q2 2025 Nuwellis Inc Earnings Call Transcript

Aug 14, 2025 / 01:00 PM GMT

Release Date Price: €6554.73

Transcript 10-Q8-K

Key Points

Positve

Nuwellis Inc (NUWE) successfully resolved a temporary backorder issue with their sterilization vendor, which had impacted revenue.
The pediatrics business segment showed strong performance with a 23% increase in revenue compared to the previous year.
The company is transitioning its manufacturing to KDI precision manufacturing, expected to result in operational efficiencies and cost savings.
Nuwellis Inc (NUWE) has increased reimbursement rates for outpatient heart failure treatment, which is expected to drive growth in this segment.
The company remains debt-free and recently raised $5 million in capital, strengthening its financial position.

Negative

Total revenue for the second quarter was $1.7 million, a 21% decline year-over-year.
Heart failure and critical care revenue declined by 53% and 35% respectively, due to the temporary backorder.
Gross margin decreased to 55.5% from 67.2% in the previous year, impacted by lower production volumes.
Operating loss increased to $2.9 million compared to $2.3 million in the same quarter last year.
Net loss attributable to common shareholders was $12.6 million, significantly higher than the $7.7 million loss in the previous year.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NUWE.OQ - Nuwellis Inc
Q2 2025 Nuwellis Inc Earnings Call
Aug 14, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
We stand by. Your program is about to begin.

Good day everyone, and welcome to today's newelis 2nd quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode.

Later, you may have the opportunity to ask questions during the question and answer session.

Please note today's call will be recorded, and I will be standing by should you need any assistance.

It is now my pleasure to turn the conference over to Lea McMullin, director of communications. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.